Adverse Effects Following Intradermal Anti-Rabies Vaccination: An Observational Study at the Largest Government Hospital of Rajasthan

Introduction: Rabies is a Lyssavirus-caused progressive, acute and lethal encephalomyelitis present in over 150 countries. Using cell culture vaccines (CCV) for post-exposure immunization is an efficient and safe preventative measure. Although CCVs are the least reactogenic, studies have shown mild to severe side effects.Objectives: To estimate the proportion of patients experiencing adverse effects after receiving intradermal anti-rabies vaccination and describe their clinico-social profile at the anti-rabies clinic, SMS Hospital, JaipurMethods: A hospital-based, descriptive, observational study was conducted among 392 animal bite patients at the anti-rabies clinic of SMS Hospital, Jaipur, Rajasthan from August 2023 to January 2024. All the patients of animal bites of Category II and III (not receiving rabies immunoglobulin) were included in the study. The collection of data was done using a pre-designed, pre-tested semi-structured questionnaire, administered by the interviewer.Results: Out of 392 animal bite patients, 301 were male (76.8%) and 91 were female (23.2%); 27% of the total reported experiencing adverse effects. Pain at the injection site (8.2%) was the most commonly reported symptom, followed by tingling sensation (4.6%), headache (4%), redness (3.6%), fever (3%), itching (2.3%) and fatigue (1.3%). Most of the symptoms appeared within 4 to 12 hours post-vaccination and resolved without any medication. No severe adverse effects following vaccination were reported.Conclusion: Some reactions were noted after administration of the vaccine by intradermal route but most were mild and self-limiting, thus the anti-rabies vaccine is a safe and effective tool against rabies and can be administered safely by intradermal route. How to cite this article:Butt A I, Rathore M, Kumari N, Singh D, Patel H. Adverse Effects Following Intradermal AntiRabies Vaccination: An Observational Study at the Largest Government Hospital of Rajasthan. APCRI J. 2024; 26(2): 5-9. DOI: https://doi.org/10.24321/0973.5038.202408

Authors

Publication Details

Journal
APCRI Journal
Published
2025-04-20
DOI
https://doi.org/10.24321/0973.5038.202408
Primary Topic
Rabies epidemiology and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adverse Effects Following Intradermal Anti-Rabies Vaccination: An Observational Study at the Largest Government Hospital of Rajasthan

Aleena Ishtiyaque Butta
APCRI Journal
Rabies epidemiology and control
article

Adverse Effects Following Intradermal Anti-Rabies Vaccination: An Observational Study at the Largest Government Hospital of Rajasthan

Aleena Ishtiyaque Butta
article en

Abstract

Introduction: Rabies is a Lyssavirus-caused progressive, acute and lethal encephalomyelitis present in over 150 countries. Using cell culture vaccines (CCV) for post-exposure immunization is an efficient and safe preventative measure. Although CCVs are the least reactogenic, studies have shown mild to severe side effects.Objectives: To estimate the proportion of patients experiencing adverse effects after receiving intradermal anti-rabies vaccination and describe their clinico-social profile at the anti-rabies clinic, SMS Hospital, JaipurMethods: A hospital-based, descriptive, observational study was conducted among 392 animal bite patients at the anti-rabies clinic of SMS Hospital, Jaipur, Rajasthan from August 2023 to January 2024. All the patients of animal bites of Category II and III (not receiving rabies immunoglobulin) were included in the study. The collection of data was done using a pre-designed, pre-tested semi-structured questionnaire, administered by the interviewer.Results: Out of 392 animal bite patients, 301 were male (76.8%) and 91 were female (23.2%); 27% of the total reported experiencing adverse effects. Pain at the injection site (8.2%) was the most commonly reported symptom, followed by tingling sensation (4.6%), headache (4%), redness (3.6%), fever (3%), itching (2.3%) and fatigue (1.3%). Most of the symptoms appeared within 4 to 12 hours post-vaccination and resolved without any medication. No severe adverse effects following vaccination were reported.Conclusion: Some reactions were noted after administration of the vaccine by intradermal route but most were mild and self-limiting, thus the anti-rabies vaccine is a safe and effective tool against rabies and can be administered safely by intradermal route. How to cite this article:Butt A I, Rathore M, Kumari N, Singh D, Patel H. Adverse Effects Following Intradermal AntiRabies Vaccination: An Observational Study at the Largest Government Hospital of Rajasthan. APCRI J. 2024; 26(2): 5-9. DOI: https://doi.org/10.24321/0973.5038.202408

APCRI JournalVol. 26(02)
Openalex Percentile: Top 81%
Rabies epidemiology and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.